NeuroCognitive Communicator: Safety Study
NCT03100110
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Tetraplegia
Interventions
DEVICE:
NeuroCognitive Communicator
Sponsor
Ottawa Hospital Research Institute